Changes to CDC’s Website Threaten Patients, Public Health
This Medical News article discusses the impact of President Donald Trump’s executive orders on the information available on CDC.gov, an important resource for clinicians, researchers, and the public. Source link
IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults
This Special Communication from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. Source link
Advances in Treatment and Prevention of HIV
Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition and provides the tools that might lead to an end of the HIV pandemic. Despite these advances, in the United States there were approximately 30 000 new infections in 2022, less than 70% of people living with HIV were virologically suppressed, […]
Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment for Early Syphilis
This secondary analysis of a randomized clinical trial assesses the incidence of Jarisch-Herxheimer reaction among adults with early syphilis treated with benzathine penicillin G and the factors associated with Jarisch-Herxheimer reaction and benzathine penicillin G treatment response outcomes. Source link
Elective Surgery for People With HIV With Low CD4 Count
This case report describes a man in his 60s with hypertension, deep vein thrombosis, and a recent diagnosis of HIV presented with low CD4 cell count after starting antiretroviral therapy with tenofovir alafenamide-emtricitabine-bictegravir. Source link
DoxyPEP Shows Promise for Reducing STIs in 2 Studies
Amid the ongoing threat of sexually transmitted infections (STIs), doxycycline postexposure prophylaxis (doxyPEP)—a preventive treatment in which individuals take a dose of doxycycline up to 3 days after unprotected sex—could help reduce cases, according to 2 studies published in JAMA Internal Medicine. Source link
Lenacapavir for Individuals Adherent to Daily Oral PrEP
This Viewpoint discusses the potential advantages of injectable preexposure prophylaxis (PrEP) drugs such as lenacapavir for persons unable to adhere to daily oral HIV PrEP and highlights ways in which lenacapavir and expanded PrEP options could offer tailored and effective ways to better meet the diverse needs of at-risk individuals. Source link
Patient Information: Genital Herpes
This JAMA Patient Page describes genital herpes and its symptoms, diagnosis, treatment, and prevention measures. Source link
The Urgent Case for Recommitting to Global HIV/AIDS Goals
This Viewpoint discusses the need to recommit to the fight against HIV/AIDS to reach the United Nation’s 2030 goal of ending the epidemic as a public health threat. Source link
Optimizing the National Response to the Syphilis and Congenital Syphilis Syndemic
This Viewpoint discusses the rising rates of syphilis cases in the US and how the federal government is leading a coordinated response to address this resurgence involving enhancing testing, treatment, and education. Source link
